Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenecteplase for Dysfunctional Hemodialysis Catheters (TROPICS 4)
NCT00396253Phase 3Completed
- Sponsor
- Genentech
- Start
- Nov 2006
- Primary completion
- Oct 2008
- Modality
- rProtein (Recombinant Protein), Biologic
01
Overview
Phase 3, open-label, single-arm trial of tenecteplase, sponsored by Genentech. Primary endpoints: Percentage of Participants Who Had Treatment Success With Respect to Blood Flow Rate (BFR) at Visit 1 and Targeted Adverse Events From the Initial Study Drug Administration Through the Start of Visit 2. Started Nov 2006; status: completed.
02
Drugs
tenecteplase
Beyond the preview
Go deeper on NCT00396253.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00396253.